Viridian Therapeutics logo
Viridian Therapeutics VRDN
$ 22.41 -1.88%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Viridian Therapeutics Operating Income 2011-2024 | VRDN

Annual Operating Income Viridian Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-254 M -134 M -79.7 M -110 M -42 M -33.1 M -26.5 M -17 M -11.2 M -6.87 M -197 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-197 K -254 M -65.1 M

Quarterly Operating Income Viridian Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-72.2 M -55.9 M - -51.2 M -59.3 M -72.5 M - -29.8 M -29.6 M -25.9 M - -14.1 M -18 M -18.5 M - -5.41 M -6.37 M -8 M - -11.2 M -8.94 M -11.7 M - -9.15 M -8.86 M -4.62 M - -5.89 M -7.35 M -6.94 M - -4.08 M -3.45 M -3.54 M - -3.13 M -2.49 M -2.61 M - -1.63 M -2.81 M -167 K - -312 K -60.4 K - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-60.4 K -72.5 M -16.6 M